Does TOCILIZUMAB Cause Basal cell carcinoma? 761 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 761 reports of Basal cell carcinoma have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 0.8% of all adverse event reports for TOCILIZUMAB.
761
Reports of Basal cell carcinoma with TOCILIZUMAB
0.8%
of all TOCILIZUMAB reports
3
Deaths
610
Hospitalizations
How Dangerous Is Basal cell carcinoma From TOCILIZUMAB?
Of the 761 reports, 3 (0.4%) resulted in death, 610 (80.2%) required hospitalization, and 23 (3.0%) were considered life-threatening.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 761 reports have been filed with the FAERS database.
What Other Side Effects Does TOCILIZUMAB Cause?
Drug ineffective (32,342)
Rheumatoid arthritis (20,652)
Pain (18,384)
Off label use (18,256)
Arthralgia (15,536)
Joint swelling (14,831)
Fatigue (13,802)
Rash (12,327)
Drug intolerance (11,952)
Contraindicated product administered (11,547)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
ALENDRONATE (610)
Which TOCILIZUMAB Alternatives Have Lower Basal cell carcinoma Risk?
TOCILIZUMAB vs TOCILIZUMAB-AAZG
TOCILIZUMAB vs TOCOPHEROL
TOCILIZUMAB vs TOFACITINIB
TOCILIZUMAB vs TOFERSEN
TOCILIZUMAB vs TOLNAFTATE